Oura's competitors fall into three groups, according to its IPO prospectus: smartwatch makers such as Apple, Google and Samsung; fitness wearables such as Garmin, Coros and Whoop; and software-onlyOura's competitors fall into three groups, according to its IPO prospectus: smartwatch makers such as Apple, Google and Samsung; fitness wearables such as Garmin, Coros and Whoop; and software-only
新手学院/Trading Guide/US Stocks/Oura Competitors: Samsung, Apple and the Smart Ring Market

Oura Competitors: Samsung, Apple and the Smart Ring Market

初阶
Sep 25, 2026James Mitchell
0 分钟
Oura's competitors fall into three groups, according to its IPO prospectus: smartwatch makers such as Apple, Google and Samsung; fitness wearables such as Garmin, Coros and Whoop; and software-only health apps. In smart rings, Oura is far ahead, with about 74% of global shipments in the first half of 2025, research firm Omdia estimates.

Key Takeaways

  • A big fish in a small pond: Oura dominates smart rings, but the 3.6 million rings it sold in the 12 months to June 30, 2026 were only about 2% of global wearable shipments. Its real competitive set is the whole wearables market.
  • Three business models: Oura charges $5.99 a month on top of the ring. Samsung's Galaxy Ring and Ultrahuman's Ring Pro need no subscription for core features. Whoop charges only a membership, with the hardware included.
  • Patents are part of the moat: an ITC ruling for Oura kept Ultrahuman out of the U.S. from October 2025 and pushed RingConn into a royalty license, but Ultrahuman has since returned with a redesigned ring.
  • Samsung is fighting back: Oura and Samsung have sued each other, and Samsung's own ITC complaint seeks restrictions on imports of certain Oura Ring products.
  • Companion as often as replacement: 37% of Oura's new members say they wear another wearable alongside the ring, while 29% say it replaced one.

Who Are Oura's Main Competitors?

Oura's main competitors are large technology companies selling general-purpose smartwatches and trackers, led by Apple, Google (including Fitbit) and Samsung. Oura's prospectus also names fitness-focused, mostly wrist-based brands such as Garmin, Coros and Whoop, plus software health companies whose apps work across devices. Inside the smart ring category, the closest rivals are Samsung, Ultrahuman and RingConn.
Oura's own framing is that most rivals are built for notifications, fitness or activity tracking, while Oura is built for continuous, long-term health tracking. That is a positioning claim as much as an analysis. It still explains where Oura chooses to fight: overnight wear, recovery and health trends rather than screens and apps.
  • Smartwatch platforms: Apple Watch, Google Pixel Watch and Fitbit, and Samsung Galaxy Watch, backed by huge installed bases, app stores and phone integration.
  • Fitness wearables: Garmin, Coros and Whoop, built around training load, strain and recovery.
  • Smart ring makers: Samsung Galaxy Ring, Ultrahuman, RingConn, Amazfit from Zepp Health, Circular, and smaller brands such as Luna and Reebok.
  • Software-only health apps: services that read data from many devices and compete for the same health-insights spending.

How Big Is Oura's Lead in the Smart Ring Market?

Oura's lead in smart rings is very large. Omdia estimates Oura shipped about 74% of the world's smart rings in the first half of 2025, against about 9% each for Ultrahuman and Samsung and 5% for RingConn. In the U.S., the category's biggest market, IDC data puts Oura's share at about 85% by the end of 2025, up from 63.3% in 2024.
The U.S. matters most because that is where most smart rings are bought. IDC counted about 2.6 million smart rings sold in the U.S. in 2025, roughly 60% of the 4.4 million sold worldwide, TechCrunch reported. IDC research manager Jitesh Ubrani told TechCrunch that Ultrahuman's U.S. share climbed from 11.5% in 2024 to 24.6% in the second quarter of 2025, then fell to low single digits once import restrictions took effect, with Oura picking up most of that ground.
Zoom out and the picture changes. Global wearable shipments were about 212 million units in the 12 months to June 30, 2026, according to IDC figures cited in the amended prospectus, and Oura's 3.6 million rings were about 2% of that. Oura wins its niche decisively. The open question for investors is how much of the far larger wrist-worn market it can take.

Oura vs Samsung Galaxy Ring: How Do They Compare?

Samsung's Galaxy Ring is Oura's most direct big-company rival. It launched in July 2024 at $399.99 and delivers Samsung Health insights without a required subscription, but it works only with Android phones. Oura charges a membership, works with both iPhone and Android, and holds far more market share. The two companies are also suing each other over patents.
  • Business model: Samsung earns on the hardware and on keeping users inside its phone and watch ecosystem, without charging for ring insights. Oura needs the membership, which is 20% of its revenue and its highest-margin line.
  • Platform reach: the Galaxy Ring's Android-only limitation cuts out iPhone owners, which is where Oura competes with Apple instead.
  • Product cadence: Samsung has not launched a second-generation ring, and there was no Galaxy Ring 2 at its July 22, 2026 Unpacked event.
  • Legal fight: Samsung filed a pre-emptive suit against Oura in 2024, which a California federal court dismissed in March 2025. Oura then sued Samsung in the Eastern District of Texas over eight patents and filed an ITC complaint against Samsung, Reebok, Zepp Health and Nexxbase. Samsung answered with a Texas lawsuit of its own and, on December 12, 2025, an ITC complaint alleging that certain Oura products infringe four Samsung patents, the S-1 discloses.
The practical reading: Samsung is the rival that can undercut Oura on the cost of ownership and afford a long legal fight. Its weaknesses are the Android-only lock-in and a ring line that has not changed since 2024.

Oura vs Apple Watch: Competitor or Companion?

Apple Watch is both. Apple is the biggest name in health wearables and keeps adding features that overlap with Oura's, including FDA-cleared hypertension notifications and a sleep score in September 2025. Yet Oura's own survey data shows many members wear a ring and a watch together: 37% of new members say they use another wearable alongside Oura.
Apple's move matters because it lands on Oura's home ground. Apple's hypertension notifications review 30 days of optical heart sensor data, run on Apple Watch Series 9 and later with watchOS 26, and were expected to flag more than 1 million people with undiagnosed hypertension in their first year. The FDA cleared the feature in September 2025. Oura's answer is Blood Pressure Signals, built on nighttime readings, and its investigational blood pressure study had enrolled more than 350,000 participants by June 30, 2026, the S-1 says.
The companion case is in the numbers too. Of Oura's new members, 33% say it is their first wearable, 29% say it replaced a device and 37% wear it alongside another one. Oura argues the finger gives a much stronger optical signal than the wrist and that a screenless ring is easier to wear overnight. Paid members wore the ring for a median of about 23 hours a day in the latest quarter.
The risk to watch is not a head-on price war. It is Apple adding enough nighttime health insight that a second device, and a second subscription, starts to look unnecessary for iPhone owners.

How Does Oura Compare With Whoop, Ultrahuman and Other Ring Makers?

Whoop is the closest match to Oura's subscription model, and Ultrahuman is its most aggressive ring rival. Whoop sells a screenless wrist band only through a yearly membership of $199 to $359. Ultrahuman sells its Ring Pro for $479 with core features free of subscription, and it returned to the U.S. in 2026 after Oura's patent win had kept it out.

What Is Oura's Competitive Moat?

Oura's moat has three layers: patents that have already won an import ban and royalties, a large base of engaged paying members backed by more than a decade of data, and healthcare partnerships that rivals have not matched. Each layer is real. Each also has a limit investors should understand.

Patents

Oura held more than 1,140 patents and patent applications at June 30, 2026, the S-1 says, and the '178 patent on the ring's internal construction delivered the Ultrahuman import ban. The limit showed up quickly. Ultrahuman designed around it, Samsung is challenging Oura's patents and suing back, and patent fights cost money on both sides.

Data and Engagement

Oura says it has collected nearly 42 billion hours of biometric data. Its members also stay: 12-month paid member retention was about 85% and the daily-to-monthly active user ratio about 65%. About 72% of members are women, and women's health, from cycle tracking to menopause, is a use case Oura has built its own AI model for. The limit is scale. Apple and Samsung collect health data from far larger installed bases.

Healthcare Partnerships

Oura connects to more than 1,200 partners. The S-1 names Natural Cycles for women's health, Strava for activity, and LillyDirect, Eli Lilly's digital health platform, and Resmed as connected-care partners, and the app shows glucose readings from Dexcom's Stelo biosensor. Lilly is also an investor: it holds a $50 million SAFE that converts into shares at the IPO and has indicated interest in buying up to $100 million of IPO shares. The limit is regulation. Oura markets most features as general wellness rather than as medical devices, while Apple already holds FDA clearances for features such as hypertension notifications.

What Could Competition Mean for Oura's Numbers?

Competition would show up in Oura's numbers in three places: ring prices, membership sign-ups and retention, and legal costs. Oura's own risk factors warn that rivals may discount hardware or offer memberships with no subscription fee. Two of its biggest ring rivals already charge no required subscription, so Oura has to keep earning the monthly fee.
Three-year cost of ownership, using U.S. list prices as of September 2026:
  • Oura Ring 5, base finish, with annual membership: $399 + 3 × $69.99 = about $609, based on Oura's published prices.
  • Samsung Galaxy Ring: $399.99, with no required subscription.
  • Ultrahuman Ring Pro: $479, with core features subscription-free.
  • Amazfit Helio Ring: $199, with no subscription.
  • Whoop One or Whoop Peak: 3 × $199 = $597, or 3 × $239 = $717, hardware included.
Over three years, an Oura owner pays about $210 more than a Galaxy Ring owner and about $130 more than an Ultrahuman owner. Oura's 85% retention says most members still think that premium is worth paying. If retention slips, or if Oura has to cut ring prices to hold share, the effect lands on the two lines investors watch most closely: membership revenue and hardware margin.

Which Oura Competitors Can You Invest In?

Of Oura's named competitors, Apple (AAPL, Nasdaq), Alphabet, Google's parent (GOOGL, Nasdaq), Garmin (GRMN, NYSE), Zepp Health (ZEPP, NYSE) and Samsung Electronics (Korea Exchange) are publicly traded. Whoop, Ultrahuman and RingConn are private. Oura itself is expected to list on Nasdaq under OURA after pricing its IPO during the week of September 28, 2026; the Oura IPO guide covers the date, price range and valuation.
On MEXC, eligible users can already trade OURAUSDT Pre-IPO Perpetual Futures, a derivative on Oura's expected share price that carries no ownership. What Is OURA Pre-IPO Futures? explains how the contract works and how to go long or short. For listed rivals, the MEXC Stocks page shows which names and products are available in your region.

Oura Competitors FAQ

Who is Oura's biggest competitor?

In smart rings, Samsung and Ultrahuman are Oura's largest rivals, each with about 9% of global shipments in the first half of 2025 against Oura's 74%, according to Omdia. Across all wearables, Apple is the biggest competitor, because Apple Watch covers many of the same sleep and heart-health features.

Is the Samsung Galaxy Ring better than Oura?

It depends on what the buyer values. The Galaxy Ring costs $399.99 with no required subscription, but it works only with Android phones and Samsung has not released a second generation. Oura costs more over time because of its membership, works with iPhone and Android, and holds far larger market share.

Why was Ultrahuman banned in the U.S.?

The U.S. International Trade Commission found that Ultrahuman's rings infringed Oura's '178 patent on smart ring construction and issued a limited exclusion order in August 2025, which took effect after October 21, 2025. U.S. Customs later ruled that Ultrahuman's redesigned Ring Pro is not covered by the order.

Does Oura charge a subscription when competitors don't?

Yes. Oura Membership costs $5.99 a month or $69.99 a year in the U.S. Samsung's Galaxy Ring, Ultrahuman's Ring Pro and Amazfit's Helio Ring do not require one for core features, while Whoop charges only a membership that includes the hardware.

What share of the smart ring market does Oura have?

About 74% of global smart ring shipments in the first half of 2025, according to Omdia, and about 85% of the U.S. market by the end of 2025, according to IDC data reported by TechCrunch.

Is Whoop a competitor to Oura?

Yes. Oura lists Whoop among its fitness-focused competitors. Whoop sells a screenless wrist band through a yearly membership of $199 to $359 and competes for the same buyers who pay for sleep and recovery insights.

Can Oura's patents stop competitors?

Partly. Oura's '178 patent led to a U.S. import ban on Ultrahuman's earlier rings and royalty licenses from RingConn and Circular. But Ultrahuman redesigned its ring to return to the U.S., and Samsung is contesting Oura's patents while pursuing its own infringement claims against Oura.

Which Oura competitors are publicly traded?

Apple, Alphabet, Garmin, Zepp Health and Samsung Electronics are publicly traded. Whoop, Ultrahuman and RingConn are private companies.
市场机遇
PortugalNationalTeam 图标
PortugalNationalTeam实时价格 (POR)
$0.07826
$0.07826$0.07826
-0.53%
USD
PortugalNationalTeam (POR) 实时价格图表

热门加密动态

查看更多
9 月 24 日美股盘前报告:Fastly逆势涨13.69%,投资者日给出2029年目标;今晚关注初请数据

9 月 24 日美股盘前报告:Fastly逆势涨13.69%,投资者日给出2029年目标;今晚关注初请数据

9 月 23 日美股三大指数全部收跌,纳指跌 1.13% 收 26,936.04 点,前一交易日才刚创下 27,244.28 点的收盘新高。导火索是 9 月综合 PMI 初值 58.4,企业投入成本涨幅创四年来最快。同一天 Fastly(FSLY)涨 13.69% 收 29.65 美元,而应用软件行业当天均值 −0.85%、纳指科技 −0.82%,所以这是逆势,不是领涨,这一截来自它自己的投资者日

BTC现货ETF单日净流入10亿美元【MEXC Alpha Trader-行业日报(2026.09.24)】

BTC现货ETF单日净流入10亿美元【MEXC Alpha Trader-行业日报(2026.09.24)】

一、宏观与市场情绪 · 行情数据:BTC $83,800(-3.89%)|ETH $2,674(-3.94%)|SOL $114.84(-3.98%) · 市场情绪:资金费率 +0.0049%|恐惧贪婪指数 71(贪婪) · 紧缩定价:10年期美债收益率升至5.081%,美元指数触及101,长端利率与美元同步抬升。延伸阅读 · 通胀预期:WTI原油触及92美元/桶,日内上涨2.82%,能源风险溢价

AI 发债狂潮:债券投资者为何开始对科技巨头“加价”?

AI 发债狂潮:债券投资者为何开始对科技巨头“加价”?

概述 一个此前被忽视的价格信号,正在成为判断 AI 资本开支周期的新坐标。据 路透社 9 月 22 日的报道,高评级信用债市场已经分裂为两个世界:金融和工业等传统发行人的债券受到热烈追捧,而 AI 相关企业的债券则遭遇谨慎对待。基金经理们并不担心这些公司会违约,真正让他们提高要价的,是为数据中心、芯片和 AI 基础设施融资所需要的规模本身,以及这种融资节奏的不可预测性。 数字把这种分歧摆在了明面上

9 月 23 日美股盘前报告:Vicor涨19.85%,增速指引一夜翻倍;今晚聚焦综合PMI

9 月 23 日美股盘前报告:Vicor涨19.85%,增速指引一夜翻倍;今晚聚焦综合PMI

上一个交易日是 9 月 22 日(周二),三大指数没有同向:纳指涨 0.45% 收 27,244.28 点、连续第二个交易日创收盘新高,道指却跌 0.36%、标普 500 基本收平(跌 0.01%)。今日焦点 **Vicor(VICR)**涨 19.85% 收 268.34 美元,市值一天从 102 亿抬到 122 亿美元;它比自己所属行业多涨 16.3 个百分点。今晚 21:45 公布 9 月综

热门新闻

查看更多
Coldcard Mk3 警告紧随 3800 万美元 Bitcoin 被扫荡事件,但原因仍未确认

Coldcard Mk3 警告紧随 3800 万美元 Bitcoin 被扫荡事件,但原因仍未确认

比特币硬件钱包制造商Coinkite已警告用户,Coldcard设备存在种子生成问题,影响从4.0.1版本起的所有Mk3固件版本。该警告是在安全研究人员调查一起涉及594.48 BTC(约合3,800万美元)的协同转移事件时发出的。然而,目前尚无公开的技术证据证实Coldcard的问题导致了这些转账。

Bitget 将退出日本:面向日本居民的服务将于 2026 年 12 月 31 日终止

Bitget 将退出日本:面向日本居民的服务将于 2026 年 12 月 31 日终止

Bitget 将于 2026 年 12 月 31 日终止对日本用户的服务。受影响的用户必须在截止日期前平仓并提取资产。

万事达完成对BVNK的收购,交易金额高达18亿美元——稳定币进入全球支付核心

万事达完成对BVNK的收购,交易金额高达18亿美元——稳定币进入全球支付核心

万事达于2026年8月3日完成了对稳定币基础设施提供商BVNK的收购,此前已于三月宣布该交易。

DEX对CEX现货交易量比率达24%,中心化交易所活动减弱

DEX对CEX现货交易量比率达24%,中心化交易所活动减弱

根据 The Block 的当前数据系列,2026年7月,去中心化交易所现货交易量与中心化交易所现货交易量之比达到24.14%。该数字并不意味着 DEX 控制了合并现货市场的24.14%:它意味着 DEX 交易量相当于数据集中包含的 CEX 交易量的24.14%。与此同时,DEX 现货交易量环比下降约26%,至约1307.7亿美元,为近两年来最低水平。

相关文章

查看更多
辉达股价预测:AI 热潮开始侵蚀辉达自己的利润了吗?

辉达股价预测:AI 热潮开始侵蚀辉达自己的利润了吗?

辉达的毛利率刚刚连续第三季度维持在接近 75% 的水准。 而在同一份新闻稿里,公司下修了这个数字的指引。 营收仍在加速——截至 2026 年 7 月 26 日的当季达 962 亿美元,比一年前的两倍还多,而下一季的指引则是 1,080 亿美元。 也就是说,公司一边加速增长,一边在每一美元营收上赚得更少;而这一组张力解释了大部分的原因,这组张力也是为什么覆盖同一家公司的分析师,连一年后的目标价都无法

AI 推理正在改变 NAND 周期吗?Sandisk 对存储芯片股意味着什么

AI 推理正在改变 NAND 周期吗?Sandisk 对存储芯片股意味着什么

AI 推理需要的不只是算力,大规模部署同样需要不断增长、能够快速访问且具备成本效率的存储容量。 NAND 正逐步成为与 HBM、DRAM 并存的 AI 容量层,而不再只是传统商品型存储产品。 Sandisk 预计,到 2030 年企业数据中心闪存需求将达到 1.2 ZB,并正在开发专门面向 AI 推理的 High Bandwidth Flash。 Sandisk、Samsung 等存储厂商开始采用

2026 AI 基础设施股票:谁真正受益于 Big Tech 的 AI 资本支出?

2026 AI 基础设施股票:谁真正受益于 Big Tech 的 AI 资本支出?

Key Takeaways Microsoft、Amazon、Alphabet 和 Meta 在 2026 年仍在大规模投入 AI 基础设施和数据中心。 Nvidia 仍是最直接的 AI 资本支出受益者之一,但 AI 云、服务器、网络和光通信也开始呈现明确增长。 CoreWeave、Nebius、Dell 和 Broadcom 提供了 AI 支出转化为营收、订单和待履约收入最清晰的证据之一。 随着

苹果(AAPL)目标价与股价预测:产能跟不上,股价还能涨到 400 美元吗?

苹果(AAPL)目标价与股价预测:产能跟不上,股价还能涨到 400 美元吗?

Key Takeaways 华尔街对苹果的共识目标价为 321.66 美元,个别分析师的预估则从 215 美元到 400 美元不等。2026 年 7 月 30 日,尽管苹果交出史上最强的 6 月当季财报、营收达 1,094 亿美元,AAPL 仍在盘后延长时段下跌约 6%。服务业务与大中华区营收双双低于分析师预估,苹果并将 9 月当季营收成长业绩指引下修至 9% 至 11%。苹果表示瓶颈在于供给而非

注册MEXC账号
注册 & 获得高达10,000 USDT奖金
你的华尔街DNA是什么?
你的华尔街DNA是什么?你的华尔街DNA是什么?
6种投资人格测试,100%中奖——$30,000等值NVDAX等你来拿!

加入 MEXC 社区

通过我们的官方 Telegram 频道,实时获取最新上币、活动和动态。

25k+ 位成员